These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 3102256)
1. PAF-acether-induced synthesis of prostacyclin by human endothelial cells. D'Humières S; Russo-Marie F; Vargaftig BB Eur J Pharmacol; 1986 Nov; 131(1):13-9. PubMed ID: 3102256 [TBL] [Abstract][Full Text] [Related]
2. Effect of BN 52021, a specific antagonist of platelet activating factor (PAF-acether), on calcium movements and phosphatidic acid production induced by PAF-acether in human platelets. Simon MF; Chap H; Braquet P; Douste-Blazy L Thromb Res; 1987 Feb; 45(4):299-309. PubMed ID: 3576518 [TBL] [Abstract][Full Text] [Related]
3. Effects of PAF-acether and structural analogues on platelet activation and bronchoconstriction in guinea-pigs. Coëffier E; Borrel MC; Lefort J; Chignard M; Broquet C; Heymans F; Godfroid JJ; Vargaftig BB Eur J Pharmacol; 1986 Nov; 131(2-3):179-88. PubMed ID: 3816952 [TBL] [Abstract][Full Text] [Related]
4. Cooperative effects of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF-acether) and exogenous arachidonic acid in stimulation of human blood platelets. Ostermann G; Till U; Thielmann K Thromb Res; 1984 Feb; 33(4):409-18. PubMed ID: 6710440 [TBL] [Abstract][Full Text] [Related]
5. The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene. Lefort J; Rotilio D; Vargaftig BB Br J Pharmacol; 1984 Jul; 82(3):565-75. PubMed ID: 6430375 [TBL] [Abstract][Full Text] [Related]
6. Binding kinetics of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) to intact human platelets. Kloprogge E; Akkerman JW Biochem J; 1984 Nov; 223(3):901-9. PubMed ID: 6150705 [TBL] [Abstract][Full Text] [Related]
7. Distinct stimulatory effect of platelet-activating factor on prostaglandin I2 and thromboxane A2 biosynthesis by rat dental pulp. Hirafuji M; Ogura Y Eur J Pharmacol; 1990 Aug; 185(1):81-90. PubMed ID: 2226634 [TBL] [Abstract][Full Text] [Related]
8. 1-O-alkyl-2-acyl-sn-glycero-3-phosphorylcholine is the precursor of platelet-activating factor in stimulated rabbit platelets. Evidence for an alkylacetyl-glycerophosphorylcholine cycle. Touqui L; Jacquemin C; Dumarey C; Vargaftig BB Biochim Biophys Acta; 1985 Jan; 833(1):111-8. PubMed ID: 3967037 [TBL] [Abstract][Full Text] [Related]
9. Regulation of PAF-acether (platelet-activating factor) biosynthesis in cultured human vascular endothelial cells stimulated with thrombin. Hirafuji M; Mencia-Huerta JM; Benveniste J Biochim Biophys Acta; 1987 Oct; 930(3):359-69. PubMed ID: 2888488 [TBL] [Abstract][Full Text] [Related]
10. Platelet-activating factor stimulates arachidonic acid metabolism in rat liver cells (C-9 cell line) by a receptor-mediated mechanism. Levine L Mol Pharmacol; 1988 Dec; 34(6):793-9. PubMed ID: 2849046 [TBL] [Abstract][Full Text] [Related]
11. Specific desensitization of rabbit platelets by platelet-activating factor (PAF-acether) and derivatives. Keraly CL; Benveniste J Br J Haematol; 1982 Jun; 51(2):313-22. PubMed ID: 7082588 [TBL] [Abstract][Full Text] [Related]
12. Platelet-activating factor (PAF-acether) formation in rat basophilic leukemia cells stimulated by ionophore A23187. Hirafuji M; Nave JF Agents Actions; 1987 Oct; 22(1-2):159-64. PubMed ID: 3120519 [TBL] [Abstract][Full Text] [Related]
13. IL-1 and related cytokines enhance thrombin-stimulated PGI2 production in cultured endothelial cells without affecting thrombin-stimulated von Willebrand factor secretion or platelet-activating factor biosynthesis. Zavoico GB; Ewenstein BM; Schafer AI; Pober JS J Immunol; 1989 Jun; 142(11):3993-9. PubMed ID: 2497185 [TBL] [Abstract][Full Text] [Related]
14. Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988. Nunez D; Chignard M; Korth R; Le Couedic JP; Norel X; Spinnewyn B; Braquet P; Benveniste J Eur J Pharmacol; 1986 Apr; 123(2):197-205. PubMed ID: 3086108 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of the metabolism of platelet activating factor (PAF-acether) by three specific antagonists from Ginkgo biloba. Lamant V; Mauco G; Braquet P; Chap H; Douste-Blazy L Biochem Pharmacol; 1987 Sep; 36(17):2749-52. PubMed ID: 2820421 [TBL] [Abstract][Full Text] [Related]
16. Production of platelet-activating factor by human vascular endothelial cells: evidence for a requirement for specific agonists and modulation by prostacyclin. Zimmerman GA; McIntyre TM; Prescott SM Circulation; 1985 Oct; 72(4):718-27. PubMed ID: 3928193 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of transmembrane movement and metabolism of platelet activating factor (PAF-acether) by a specific antagonist, BN 52021. Lachachi H; Plantavid M; Simon MF; Chap H; Braquet P; Douste-Blazy L Biochem Biophys Res Commun; 1985 Oct; 132(2):460-6. PubMed ID: 2998370 [TBL] [Abstract][Full Text] [Related]
18. PAF-acether induced arterial thrombosis and the effect of specific antagonists. Bourgain RH; Andries R; Esanu A; Braquet P Adv Exp Med Biol; 1992; 316():427-40. PubMed ID: 1288104 [TBL] [Abstract][Full Text] [Related]
19. Paf-acether formation and arachidonic acid freeing from platelet ether-linked glyceryl-phosphorylcholine. Chignard M; Le Couedic JP; Coëffier E; Benveniste J Biochem Biophys Res Commun; 1984 Oct; 124(2):637-43. PubMed ID: 6437404 [TBL] [Abstract][Full Text] [Related]
20. A role for PAF-acether (platelet-activating factor) in platelet-dependent vascular diseases? Benveniste J; Chignard M Circulation; 1985 Oct; 72(4):713-7. PubMed ID: 3928192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]